Salem Investment Counselors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Salem Investment Counselors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-850	Closed	-$3K	–	1149
2021 Q3	$3K	Hold	850	–	–	﹤0.01%	897
2021 Q2	$4K	Hold	850	–	–	﹤0.01%	809
2021 Q1	$4K	Hold	850	–	–	﹤0.01%	779
2020 Q4	$3K	Hold	850	–	–	﹤0.01%	750
2020 Q3	$3K	Hold	850	–	–	﹤0.01%	646
2020 Q2	$4K	Hold	850	–	–	﹤0.01%	617
2020 Q1	$4K	Hold	850	–	–	﹤0.01%	602
2019 Q4	$3K	Hold	850	–	–	﹤0.01%	649
2019 Q3	$7K	Hold	850	–	–	﹤0.01%	558
2019 Q2	$8K	Buy	+850	New	+$6.41K	﹤0.01%	569
2017 Q2	–	Sell	-500	Closed	-$15K	–	818
2017 Q1	$15K	Buy	+500	New	+$12.8K	﹤0.01%	499

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Salem Investment Counselors's LJPC Position: Q4 2021 in Review

Salem Investment Counselors sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 850 shares — an estimated $3K sold.

Salem Investment Counselors first reported a position in LJPC in Q1 2017 and held it in 11 quarters. The position peaked at $15K in Q1 2017. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

Salem Investment Counselors reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
Salem Investment Counselors sold 850 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $3K.
Salem Investment Counselors first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 11 quarters.
Salem Investment Counselors's La Jolla Pharmaceutical Company position peaked at $15K in Q1 2017.
44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Salem Investment Counselors's 13F filing for Q4 2021, filed 15 Feb 2022.